Generic name: Technetium Tc99m Sestamibi
Dosage form: Kit for the Preparation of Injection
Medically reviewed on February 22, 2018.
For Myocardial Imaging: The suggested dose range for I.V. administration of CARDIOLITE® in a single dose to be employed in the average patient (70 Kg) is 370-1110 MBq (10-30 mCi).
For Breast Imaging: The recommended dose range for I.V. administration of MIRALUMA® is a single dose of 740-1110 MBq (20-30 mCi).
Breast Imaging: It is recommended that images are obtained with a table overlay to separate breast tissue from the myocardium and liver, and to exclude potential activity that may be present in the opposite breast. For lateral images, position the patient prone with the isolateral arm comfortably above the head, shoulders flat against the table, head turned to the side and relaxed, with the breast imaged pendent through an overlay cutout. The breast should not be compressed on the overlay. For anterior images, position the patient supine with both arms behind the head. For either lateral or anterior images, shield the chest and abdominal organs, or remove them from the field of view.
For complete study, sets of images should be obtained five minutes after the injection, and in the following sequence:
Beginning five minutes after the injection of Technetium Tc99m Sestamibi:
- ten-minute lateral image of breast with abnormality
- ten-minute lateral image of contralateral breast
- ten-minute anterior image of both breasts
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.